Related Experiment Video
Updated: Feb 23, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Mitochondrial cyclophilin D ablation is associated with the activation of Akt/p70S6K pathway in the mouse kidney
Jelena Klawitter1,2, Alexander Pennington3, Jost Klawitter3
1Department of Anesthesiology, University of Colorado Denver, Aurora, Colorado, USA. Jelena.Klawitter@ucdenver.edu.
Abstract:
The mitochondrial matrix protein cyclophilin D (CypD) is an essential component of the mitochondrial permeability transition pore (MPTP). Here we characterized the effects of CypD ablation on bioenergetics in the kidney. CypD loss triggers a metabolic shift in Ppif-/- male and female mouse kidneys towards glycolysis and Krebs cycle activity. The shift is accompanied by increased glucose consumption and a transcriptional upregulation of effectors of glucose metabolism in the kidney. These included activation of Akt, AMPK (only in males) and p70S6K kinases. Gender specific differences between the Ppif-/- male and female mouse kidneys were observed including activation of pro-surviving ERK1/2 kinase and inhibited expression of pro-apoptotic and pro-fibrotic JNK and TGFβ1 proteins in Ppif-/- females. They also showed the highest expression of phosphorylated-ERK1/2 and Akt S473 proteins of all four investigated animal groups. Furthermore, Ppif-/- females showed higher lactate concentrations and ATP/ADP-ratios in the kidney than males. These metabolic and transcriptional modifications could provide an additional level of protection to Ppif-/- females. In summary, loss of mitochondrial CypD results in a shift in bioenergetics and in activation of glucose-metabolism regulating Akt/AMPK/p70S6 kinase pathways that is expected to affect the capability of Ppif-/- mice kidneys to react to stimuli and injury.
Insights
Mitochondrial protein cyclophilin D (CypD) loss shifts kidney metabolism towards glycolysis. This metabolic reprogramming, particularly in females, may enhance kidney resilience against injury.
Area of Science:
- Mitochondrial Biology
- Renal Physiology
- Metabolic Regulation
Background:
- Cyclophilin D (CypD) is a key component of the mitochondrial permeability transition pore (MPTP).
- Understanding CypD's role in kidney bioenergetics is crucial for metabolic disease research.
Purpose of the Study:
- To investigate the impact of CypD ablation on kidney bioenergetics in mice.
- To identify sex-specific metabolic and transcriptional changes following CypD loss.
Main Methods:
- Analysis of kidney bioenergetics in CypD-ablated (Ppif-/-) and wild-type mice.
- Assessment of metabolic pathways, including glycolysis and Krebs cycle activity.
- Transcriptional analysis of key metabolic regulators and signaling pathways (Akt, AMPK, p70S6K, ERK1/2, JNK, TGFβ1).
Main Results:
- CypD loss induces a metabolic shift towards glycolysis and Krebs cycle activity in mouse kidneys.
- Increased glucose consumption and upregulation of glucose metabolism effectors were observed.
- Sex-specific differences emerged, with Ppif-/- females exhibiting enhanced pro-survival signaling (ERK1/2) and inhibited pro-apoptotic/fibrotic markers (JNK, TGFβ1).
- Ppif-/- females demonstrated higher lactate concentrations and ATP/ADP ratios compared to males.
Conclusions:
- Loss of mitochondrial CypD significantly alters kidney bioenergetics, activating glucose metabolism pathways.
- These adaptations, particularly pronounced in females, suggest a potential protective mechanism against kidney injury.
- Further research into these metabolic shifts could inform therapeutic strategies for kidney diseases.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
13:15Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity